Export

Glatiramer acetate
Essential medicine status
General description

ATC codes
Medicine type
Chemical agent
EML status history
Application rejected in 2019 (TRS 1021) for Relapsing-remitting multiple sclerosis
Added in 2023 (TRS 1049) for Multiple sclerosis
Recommendations
Section
Medicines for multiple sclerosis
  • Parenteral > General injections > SC: 20 mg per mL; 40 mg per mL
  • Parenteral > General injections > SC: 20 mg per mL in pre-filled syringe; 40 mg per mL in pre-filled syringe